These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23679916)

  • 1. Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery.
    Wu J; Song C; Jiang C; Shen X; Qiao Q; Hu Y
    Mol Pharm; 2013 Oct; 10(10):3555-63. PubMed ID: 23679916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.
    Soundararajan S; Chen W; Spicer EK; Courtenay-Luck N; Fernandes DJ
    Cancer Res; 2008 Apr; 68(7):2358-65. PubMed ID: 18381443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
    J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
    Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
    Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
    Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J; Mokhtarzadeh A
    Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.
    Ding D; Tang X; Cao X; Wu J; Yuan A; Qiao Q; Pan J; Hu Y
    AAPS PharmSciTech; 2014 Feb; 15(1):213-22. PubMed ID: 24287627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.
    Feng Q; Yu MZ; Wang JC; Hou WJ; Gao LY; Ma XF; Pei XW; Niu YJ; Liu XY; Qiu C; Pang WH; Du LL; Zhang Q
    Biomaterials; 2014 Jun; 35(18):5028-38. PubMed ID: 24680191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
    Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
    Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.
    Yu B; Tang C; Yin C
    Biomaterials; 2014 Aug; 35(24):6369-78. PubMed ID: 24818887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Carbon Nanotube-Based Breast Cancer Drug Delivery System: Preparation and In Vitro Analysis Using Paclitaxel.
    Shao W; Paul A; Rodes L; Prakash S
    Cell Biochem Biophys; 2015 Apr; 71(3):1405-14. PubMed ID: 27101155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heparin binding motif of endostatin mediates its interaction with receptor nucleolin.
    Fu Y; Chen Y; Luo X; Liang Y; Shi H; Gao L; Zhan S; Zhou D; Luo Y
    Biochemistry; 2009 Dec; 48(49):11655-63. PubMed ID: 19877579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells.
    Soundararajan S; Wang L; Sridharan V; Chen W; Courtenay-Luck N; Jones D; Spicer EK; Fernandes DJ
    Mol Pharmacol; 2009 Nov; 76(5):984-91. PubMed ID: 19657047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective collection and detection of MCF-7 breast cancer cells using aptamer-functionalized magnetic beads and quantum dots based nano-bio-probes.
    Hua X; Zhou Z; Yuan L; Liu S
    Anal Chim Acta; 2013 Jul; 788():135-40. PubMed ID: 23845492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
    Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
    Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer.
    Hwang DW; Ko HY; Lee JH; Kang H; Ryu SH; Song IC; Lee DS; Kim S
    J Nucl Med; 2010 Jan; 51(1):98-105. PubMed ID: 20008986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Click conjugation of peptide to hydrogel nanoparticles for tumor-targeted drug delivery.
    Qin M; Zong H; Kopelman R
    Biomacromolecules; 2014 Oct; 15(10):3728-34. PubMed ID: 25162488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
    Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.